RxDoctor Payments Data

Madison Gilmore, PA

Physician Assistant · McKinney, TXNPI 1326618398

Payments from drug & device makers

$7,402in general payments, 2019–2025

Across 225 payments — averaging $32.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$940
  • Sun Pharmaceutical Industries Inc.$656
  • Dermavant Sciences, Inc.$458
  • UCB, Inc.$409
  • Incyte Corporation$374
  • plus $3K from 22 others

What the payments were for

  • Speaking & faculty fees$2083%
  • Food & beverage$6,53088%
  • Education$6649%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,402 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$6,466
Medicare patients
41
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole19$15,282
Tacrolimus17$2,276
Clobetasol Propionate32$1,681
Metronidazole30$1,269
Ketoconazole74$1,096
Doxycycline Hyclate34$1,058
Triamcinolone Acetonide99$849
Fluorouracil14$572
Mupirocin67$491
Nystatin13$182
Hydrocortisone14$74

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$194$15,28219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in McKinney

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →